<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02561533</url>
  </required_header>
  <id_info>
    <org_study_id>TIHCDBMTC1</org_study_id>
    <nct_id>NCT02561533</nct_id>
  </id_info>
  <brief_title>Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma</brief_title>
  <official_title>Immunohistochemical Detection of the BRAFV600E Mutation on Cytological Specimen in PTC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Immunohistochemical detection of the BRAF-V600E mutation on pre-operative fine needle
      aspiration biopsy (FNAB) from patients suspected for papillary thyroid carcinoma, using the
      mutation specific antibody VE1.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The BRAF mutation is reported to be present in approximately 50% of papillary thyroid
      carcinomas (PTC). The mutation has been associated with poor prognosis and more advanced
      disease stage. Therefore, pre-operative detection of the BRAF-V600E mutation may be of
      clinical interest in order to individualize treatment of patients with BRAF positive PTC.

      FNABs are performed immediately before the thyroid operation, and BRAF-V600E detection using
      VE1 is performed on clots. The VE1 stain is compared to the mutation status of the removed
      cancer or control tissue using the Cobas test.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immunohistochemical detection of BRAF mutation on fine needle aspiration biopsy (FNAB)</measure>
    <time_frame>1 day</time_frame>
    <description>Mutations status correlated to histological diagnoses and mutation status on histological samples</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Papillary Thyroid Carcinoma</condition>
  <arm_group>
    <arm_group_label>BRAF immunohistochemistry (IHC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BRAF detection on fine needle aspiration biopsy (FNAB)</intervention_name>
    <arm_group_label>BRAF immunohistochemistry (IHC)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bethesda system of reporting thyroid cytology (BSRTC) group 5-6 on pre-operative FNAB
             from the nodule (&gt;1cm)

          -  Undergoing thyroid surgery (histology of index nodule)

        Exclusion Criteria:

          -  Not undergoing thyroid surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus C</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2015</study_first_submitted>
  <study_first_submitted_qc>September 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2015</study_first_posted>
  <last_update_submitted>July 13, 2017</last_update_submitted>
  <last_update_submitted_qc>July 13, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Aarhus</investigator_affiliation>
    <investigator_full_name>Kristine ZÃ¸ylner Rubeck</investigator_full_name>
    <investigator_title>MD PhD-student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

